Profil
Liliana Bar worked as a Director of Development & Base Business Unit at OMRIX Biopharmaceuticals, Inc. She then worked as Vice President of Research & Development at Kamada Ltd.
from 2012 to 2019.
Dr. Bar received her undergraduate, graduate, and doctorate degrees from The Hebrew University of Jerusalem.
Anciens postes connus de Liliana Bar
| Sociétés | Poste | Fin |
|---|---|---|
| KAMADA LTD. | Chief Tech/Sci/R&D Officer | 01/02/2019 |
OMRIX Biopharmaceuticals, Inc.
 OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Corporate Officer/Principal | - |
Formation de Liliana Bar
| The Hebrew University of Jerusalem | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KAMADA LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
OMRIX Biopharmaceuticals, Inc.
OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Health Technology |
